Successful surgical treatment of chronic ischemic mitral regurgitation achieves left ventricular reverse remodeling but does not affect right ventricular.

Slides:

Advertisements

Similar presentations

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Manuel J. Antunes, MD, PhD, DSc

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

Can papillary muscle interventions improve mitral valve repair durability for ischemic mitral regurgitation? Christos G. Mihos, DO, Orlando Santana,

Intraoperative bypass graft flow in intra-aortic balloon pump–supported patients: Differences in arterial and venous sequential conduits Francesco Onorati,

In which patients is transcatheter aortic valve replacement potentially better indicated than surgery for redo aortic valve disease? Long-term results.

Enhanced left ventricular mass regression after aortic valve replacement in patients with aortic stenosis is associated with improved long-term survival

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients Björn.

Ultrasound, endoscopy, and the recurrent nerve

Pulmonary hypertension in valve disease: A beast of the past?

Intrinsic cardiac stem cells are essential for regeneration

Abracadabra I, II…HeartMate 3?

Victor van Berkel, MD, PhD

William M. DeCampli, MD, PhD

A new approach: Ischemic mitral regurgitation guidelines by and for surgeons Patrick M. McCarthy, MD The Journal of Thoracic and Cardiovascular Surgery

It is still mostly about the mitral valve

Go on-pump or off-pump in diabetic patients?

The lord of the rings Antonio Miceli, MD, PhD

Ventricular assist device abdominal driveline infection: Treatment with platelet-rich plasma Federica Jiritano, MD, Giuseppe Filiberto Serraino, MD,

Jared P. Beller, MD, Irving L. Kron, MD

In type A aortic dissection repair, an effective team approach and relational coordination are more important for patients' outcomes than surgeon volume

Aldo R. Castañeda, MD, PhD: Recipient of the Lifetime Achievement Award and 74th president of The American Association for Thoracic Surgery Pedro J.

Baseline left ventricular function and surgical annular stiffening to predict outcome and reverse left ventricular remodeling after undersized annuloplasty.

Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology Juan A. Crestanello, MD The Journal of.

Franco Stella, MD, PhD, Francesco Petrella, MD

The variability of the mitral valve anatomy and terminology

Is subvalvular repair worthwhile in severe ischemic mitral regurgitation? Subanalysis of the Papillary Muscle Approximation trial Francesco Nappi, MD,

Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.

Long-term outcome of patients on continuous-flow left ventricular assist device support Koji Takeda, MD, PhD, Hiroo Takayama, MD, PhD, Bindu Kalesan,

A near 100% repair rate for mitral valve prolapse is achievable in a reference center: Implications for future guidelines Javier G. Castillo, MD, Anelechi.

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Long-term outcome of combined valve repair and maze procedure for nonrheumatic mitral regurgitation Tomoyuki Fujita, MD, Junjiro Kobayashi, MD, Koichi.

Long-term clinical results of mitral valvuloplasty using flexible and rigid rings: A prospective and randomized study Byung-Chul Chang, MD, Young-Nam.

Radial artery graft function is not affected by age

A first start for lung transplantation?

Get it right the first time

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Tirone E. David, MD, Gheorghe Gavra, MD, Christopher M

Historical perspectives of The American Association for Thoracic Surgery: Robert M. Janes, MD ( ) Myunghyun Lee, MD, Vivek Rao, MD, PhD The.

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Leora B. Balsam, MD, Abe DeAnda, MD

Midterm clinical and echocardiographic results and predictors of mitral regurgitation recurrence following restrictive annuloplasty for ischemic cardiomyopathy

Replicating the success of mitral valve repair in the aortic valve

Anticoagulation with apixaban in a patient with a left ventricular assist device and gastrointestinal bleeding: A viable alternative to warfarin? Francesco.

The Ross procedure: Time to reevaluate the guidelines

Manuel J. Antunes, MD, PhD, DSc

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Commentary: Three-dimensional P3 tethering angle at the heart of future surgical decision making in ischemic mitral regurgitation Wobbe Bouma, MD, PhD,

Innovation in cardiothoracic surgical training

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Constantine L. Athanasuleas, MD, FACC

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Severe tricuspid or mitral regurgitation in inoperable patients with aortic stenosis. Can we leave them alone? Juan A. Crestanello, MD The Journal of.

The future of cardiac surgery training: A survival guide

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

Tricuspid annulus diameter does not predict the development of tricuspid regurgitation after mitral valve repair for mitral regurgitation due to degenerative.

Ralph E. Delius, MD The Journal of Thoracic and Cardiovascular Surgery

Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD

“The more things change…”: The challenges ahead

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Ryan R. Davies, MD The Journal of Thoracic and Cardiovascular Surgery

Francesco Nappi, MD, Cristiano Spadaccio, MD, PhD

Preoperative PFTs: The answer is blowing in the wind

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

Did you like Terminator 3 better than Terminator 2

A good chimney requires a good sweep

How do we follow up our patients

The papillary muscle sling for ischemic mitral regurgitation

Presentation transcript:

Successful surgical treatment of chronic ischemic mitral regurgitation achieves left ventricular reverse remodeling but does not affect right ventricular function Francesco Onorati, MD, Giuseppe Santarpino, MD, Domenico Marturano, MD, Antonino S. Rubino, MD, Eugenia Pasceri, MD, Stefania Zinzi, MD, Giuseppina Mascaro, MD, Lucia Cristodoro, MD, Attilio Renzulli, MD, PhD, FETCS The Journal of Thoracic and Cardiovascular Surgery Volume 138, Issue 2, Pages 341-351 (August 2009) DOI: 10.1016/j.jtcvs.2008.12.034 Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Actuarial survival (A), and freedom from CHF (B), hospitalization (C), and reintervention (D). The Journal of Thoracic and Cardiovascular Surgery 2009 138, 341-351DOI: (10.1016/j.jtcvs.2008.12.034) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Freedom from ≥ 2+ CIMR recurrence (A) and freedom from CHF (B), hospitalization (C), and reintervention (D) between patients with and without CIMR recurrence. CIMR, Chronic ischemic mitral regurgitation. The Journal of Thoracic and Cardiovascular Surgery 2009 138, 341-351DOI: (10.1016/j.jtcvs.2008.12.034) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Actuarial freedom from CHF (A), hospitalization (B), and recurrent CIMR (C) between patients with preoperative LVEDD ≥ 70 mm and patients with preoperative LVEDD < 70 mm. LVEDD, Left ventricular end-diastolic diameter. The Journal of Thoracic and Cardiovascular Surgery 2009 138, 341-351DOI: (10.1016/j.jtcvs.2008.12.034) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions